Impacts of Prior Anti-Osteoporosis Treatments on Sequential Denosumab Responses in BMD Changes Among Postmenopausal Osteoporosis Women in East China: Real-World Data Analysis
These findings indicated that prior anti-osteoporosis treatments differentially influenced BMD responses to 1-year Dmab therapy. While patients who had previously been treated with ZOL had limited subsequent BMD improvement, patients who had previously used TPT and had lower baseline BMD benefited more.
Authors
- Wenjing Tang (ORCID: https://orcid.org/0000-0002-9086-4827)
- Minmin Chen (ORCID: https://orcid.org/0000-0002-0734-2922)
- Guoyu Guan (ORCID: https://orcid.org/0000-0001-8705-8421)
- Huilin Li (ORCID: https://orcid.org/0000-0002-8288-7068)
- Weijia Yu (ORCID: https://orcid.org/0000-0001-5629-056X)
- Qun Cheng
- Yanping Du (ORCID: https://orcid.org/0000-0001-7225-1923)
Institutions
- Huadong Hospital (CN)
Publication Details
- Journal
- Clinical Interventions in Aging
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/cia.s511622
- Citations
- 1
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Shanghai Key Laboratory of Clinical Geriatric Medicine
- National Natural Science Foundation of China
- National Key Research and Development Program of China